Pages that link to "Q34242907"
Jump to navigation
Jump to search
The following pages link to New insights into the pathogenesis of Behçet's disease (Q34242907):
Displaying 50 items.
- Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease (Q26779170) (← links)
- Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives (Q26799767) (← links)
- Pathological implications of Th1/Th2 cytokine genetic variants in Behçet's disease: Data from a pilot study in a Sicilian population. (Q30655444) (← links)
- Identification of possible pathogenic pathways in Behçet's disease using genome-wide association study data from two different populations (Q30852088) (← links)
- Genetic origin of Behçet's disease population in Denizli, Turkey; population genetics data analysis; historical demography and geographical perspectives based on β-globin gene cluster haplotype variation (Q31151856) (← links)
- Serum PLR and LMR in Behçet's disease: Can they show the disease activity? (Q33760602) (← links)
- Low prevalence of obesity in Behçet's disease is associated with high obestatin level. (Q33806655) (← links)
- Decreased expression of the aryl hydrocarbon receptor in ocular Behcet's disease (Q33876252) (← links)
- Biological treatments in Behçet's disease: beyond anti-TNF therapy. (Q33908217) (← links)
- Immunopathogenesis of ocular Behçet's disease (Q33908937) (← links)
- Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum. (Q34377832) (← links)
- Intense pulsed light in the treatment of telangiectasias: case report of Behçet's disease with superficial vascular involvement (Q35019037) (← links)
- Annexin A2 as a target endothelial cell membrane autoantigen in Behçet's disease (Q35035563) (← links)
- Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report (Q35062816) (← links)
- Cytokines Modulate the "Immune-Metabolism" Interactions during Behçet Disease: Effect on Arginine Metabolism (Q35066832) (← links)
- High prevalence of Helicobacter pylori infection in Behcet's disease (Q35135666) (← links)
- Differential expression of suppressor of cytokine signalling proteins in Behçet's disease (Q35245711) (← links)
- Electron Transfer Flavoprotein Subunit Beta Is a Candidate Endothelial Cell Autoantigen in Behçet's Disease (Q35542134) (← links)
- Interleukin-10 gene polymorphisms are associated with Behcet's disease but not with Vogt-Koyanagi-Harada syndrome in the Chinese Han population (Q35645864) (← links)
- A Comparative Metabolomic Evaluation of Behcet's Disease with Arthritis and Seronegative Arthritis Using Synovial Fluid (Q35745021) (← links)
- Molecular Dynamics Simulation Reveals the Selective Binding of Human Leukocyte Antigen Alleles Associated with Behçet's Disease (Q35762095) (← links)
- Increased expression of the NLRP3 inflammasome components in patients with Behçet's disease (Q35806208) (← links)
- Behçet's: A Disease or a Syndrome? Answer from an Expression Profiling Study (Q35927096) (← links)
- Association between the methylene tetrahydrofolate reductase gene C677T mutation and colchicine unresponsiveness in Behcet's disease (Q36073870) (← links)
- Inflammation-related cytokine gene polymorphisms in Behçet's disease (Q36116573) (← links)
- Decreased B and T lymphocyte attenuator in Behcet's disease may trigger abnormal Th17 and Th1 immune responses (Q36542187) (← links)
- Behçet's disease physiopathology: a contemporary review (Q36573124) (← links)
- Genetic polymorphisms of cell adhesion molecules in Behcet's disease in a Chinese Han population (Q36830250) (← links)
- HnRNP A1 is Involved in Deep Vein Thrombosis Patients with Behçet's Disease (Q36870010) (← links)
- MicroRNAs differentially expressed in Behçet disease are involved in interleukin-6 production (Q37111357) (← links)
- Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet's disease: an updated meta-analysis (Q37175793) (← links)
- Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study (Q37205638) (← links)
- Update on the Medical Management of Gastrointestinal Behçet's Disease. (Q37624811) (← links)
- Vitamin D deficiency in patients with Behcet's disease (Q37717574) (← links)
- Febrile conditions in rheumatology (Q38038102) (← links)
- Refractory pemphigus foliaceus and Behçet's disease successfully treated with tocilizumab (Q38097750) (← links)
- Skin rash and arthritis a simplified appraisal of less common associations (Q38131831) (← links)
- Systemic use of non-biologic agents in orofacial diseases: other immunomodulatory agents (Q38136748) (← links)
- Neutrophil migration: moving from zebrafish models to human autoimmunity. (Q38151856) (← links)
- Refractory pseudoseptic arthritis in Behçet's disease successfully treated with infliximab: a case report and literature review. (Q38164832) (← links)
- Behçet's syndrome pathophysiology and potential therapeutic targets (Q38177749) (← links)
- The role of microRNAs in autoimmune diseases with skin involvement. (Q38272151) (← links)
- Management of severe complications in Behçet's disease with TNF inhibitors. (Q38786414) (← links)
- New therapeutic solutions for Behçet's syndrome (Q38830790) (← links)
- Ex vivo immunomodulatory effect of all-trans-retinoic acid during Behçet's disease: a study in Algerian patients (Q38974399) (← links)
- Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches (Q39426072) (← links)
- Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review (Q40045785) (← links)
- PFAPA syndrome and Behçet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists (Q40170236) (← links)
- Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study (Q40756639) (← links)
- Transcription Factors Regulating Inflammatory Cytokine Production Are Differentially Expressed in Peripheral Blood Mononuclear Cells of Behçet Disease Depending on Disease Activity (Q41866475) (← links)